These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20198408)

  • 21. Accumulation of Charantin and Expression of Triterpenoid Biosynthesis Genes in Bitter Melon (Momordica charantia).
    Cuong DM; Jeon J; Morgan AMA; Kim C; Kim JK; Lee SY; Park SU
    J Agric Food Chem; 2017 Aug; 65(33):7240-7249. PubMed ID: 28737900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer preventive potential of Momordica charantia L. against benzo(a)pyrene induced fore-stomach tumourigenesis in murine model system.
    Deep G; Dasgupta T; Rao AR; Kale RK
    Indian J Exp Biol; 2004 Mar; 42(3):319-22. PubMed ID: 15233304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bitter melon extract inhibits proliferation of Trypanosoma brucei bloodstream forms in vitro.
    Phillips EA; Sexton DW; Steverding D
    Exp Parasitol; 2013 Mar; 133(3):353-6. PubMed ID: 23266484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of Bitter Melon (Momordica charantia) Extract on the Uptake of
    Kilcar AY; Yildiz O; Dogan T; Sulu E; Takan G; Muftuler FZB
    Anticancer Agents Med Chem; 2020; 20(12):1497-1503. PubMed ID: 32329694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dangerous interaction of bitter melon (
    Unsal O; Sütcüoğlu O; Yazıcı O
    J Oncol Pharm Pract; 2022 Mar; 28(2):486-488. PubMed ID: 34569860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis.
    Ray RB; Raychoudhuri A; Steele R; Nerurkar P
    Cancer Res; 2010 Mar; 70(5):1925-31. PubMed ID: 20179194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Bitter Melon in Breast and Gynecological Cancer Prevention and Therapy.
    Psilopatis I; Vrettou K; Giaginis C; Theocharis S
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells.
    Xiong SD; Yu K; Liu XH; Yin LH; Kirschenbaum A; Yao S; Narla G; DiFeo A; Wu JB; Yuan Y; Ho SM; Lam YW; Levine AC
    Int J Cancer; 2009 Aug; 125(4):774-82. PubMed ID: 19384952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and Characterization of Phenylpropanoid Biosynthetic Genes and Their Accumulation in Bitter Melon (Momordica charantia).
    Cuong DM; Kwon SJ; Jeon J; Park YJ; Park JS; Park SU
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29466305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxicity analysis of active components in bitter melon (Momordica charantia) seed extracts using human embryonic kidney and colon tumor cells.
    Chipps ES; Jayini R; Ando S; Protzman AD; Muhi MZ; Mottaleb MA; Malkawi A; Islam MR
    Nat Prod Commun; 2012 Sep; 7(9):1203-8. PubMed ID: 23074909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bitter melon (Momordica charantia) extract suppresses adrenocortical cancer cell proliferation through modulation of the apoptotic pathway, steroidogenesis, and insulin-like growth factor type 1 receptor/RAC-α serine/threonine-protein kinase signaling.
    Brennan VC; Wang CM; Yang WH
    J Med Food; 2012 Apr; 15(4):325-34. PubMed ID: 22191569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets.
    Jayasooriya AP; Sakono M; Yukizaki C; Kawano M; Yamamoto K; Fukuda N
    J Ethnopharmacol; 2000 Sep; 72(1-2):331-6. PubMed ID: 10967491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticancer Activity of Bitter Melon-Derived Vesicles Extract against Breast Cancer.
    Feng T; Wan Y; Dai B; Liu Y
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effects of bitter melon (Momordica charantia Linn.) on bacterial mutagenesis and aberrant crypt focus formation in the rat colon.
    Chiampanichayakul S; Kataoka K; Arimochi H; Thumvijit S; Kuwahara T; Nakayama H; Vinitketkumnuen U; Ohnishi Y
    J Med Invest; 2001 Feb; 48(1-2):88-96. PubMed ID: 11286022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antioxidant properties and quantitative UPLC-MS analysis of phenolic compounds from extracts of fenugreek (Trigonella foenum-graecum) seeds and bitter melon (Momordica charantia) fruit.
    Kenny O; Smyth TJ; Hewage CM; Brunton NP
    Food Chem; 2013 Dec; 141(4):4295-302. PubMed ID: 23993618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-κB and JNK pathways in high-fat-fed OLETF rats.
    Yang SJ; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY
    J Nutr Biochem; 2015 Mar; 26(3):234-40. PubMed ID: 25488547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of superfine grinding on physical properties, bioaccessibility, and anti-obesity activities of bitter melon powders.
    Zhu Y; Bai J; Qian X; Yang X; Zhou X; Zhao Y; Dong Y; Xiao X
    J Sci Food Agric; 2022 Aug; 102(11):4473-4483. PubMed ID: 35122268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxysterols and lipidomic profile of myocardium of rats supplemented with pomegranate seed oil and/or bitter melon aqueous extract - Cardio-oncological animal model research.
    Białek A; Białek M; Lepionka T; Pachniewicz P; Czauderna M
    Chem Phys Lipids; 2021 Mar; 235():105057. PubMed ID: 33515592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimized aqueous extraction of saponins from bitter melon for production of a saponin-enriched bitter melon powder.
    Tan SP; Vuong QV; Stathopoulos CE; Parks SE; Roach PD
    J Food Sci; 2014 Jul; 79(7):E1372-81. PubMed ID: 25041538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bitter gourd (Momordica charantia) as a rich source of bioactive components to combat cancer naturally: Are we on the right track to fully unlock its potential as inhibitor of deregulated signaling pathways.
    Farooqi AA; Khalid S; Tahir F; Sabitaliyevich UY; Yaylim I; Attar R; Xu B
    Food Chem Toxicol; 2018 Sep; 119():98-105. PubMed ID: 29753870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.